Last updated on February 2018

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies


Brief description of study

This study is a Phase 1, Non-randomized, Open-label/Phase 2 Randomized, Blinded Study of ProTmune (ex vivo programmed mobilized peripheral blood cells) Versus Non-programmed mobilized peripheral blood cells for Allogeneic Hematopoietic Cell Transplantation (HCT) in Adult Subjects Aged 18 to 70 years with Hematologic Malignancies. A maximum of 70 total eligible subjects will be enrolled and treated in the trial at approximately 15-20 centers in the US and EU.

Clinical Study Identifier: NCT02743351

Contact Investigators or Research Sites near you

Start Over

Chatchada Karanes, MD

City of Hope
Duarte, CA United States
  Connect »

John R Edwards, MD

Indiana Blood and Marrow Transplant
Indianapolis, IN United States
  Connect »

Abhinav Deol, MD

Barbara Ann Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Carlos Bachier, MD

Sarah Cannon Research Institute
Nashville, TN United States
  Connect »

John McCarty, MD

Virginia Commonwealth University
Richmond, VA United States
  Connect »

Ayman Saad, MD

University of Alabama
Birmingham, AL United States
  Connect »

Dimitrios Tzachanis, MD

University of California, San Diego (UCSD) Moores Cancer Center
San Diego, CA United States
  Connect »

Michael Bishop

University of Chicago
Chicago, IL United States
  Connect »

Corey Cutler, MD

Dana Farber Cancer Institute
Boston, MA United States
  Connect »

Koen Van Besien, MD

Weill Cornell Medicine
New York, NY United States
  Connect »

James Essell, MD

Jewish Hospital
Cincinnati, OH United States
  Connect »

Richard Maziarz, MD

Oregon Health & Science University
Portland, OR United States
  Connect »

Cesar Freytes, MD

Texas Transplant Institute
San Antonio, TX United States
  Connect »

Daniel Couriel, MD

Huntsman Cancer Institute (University of Utah)
Salt Lake City, UT United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.